Amorepacific Corp. (New) (090430)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 124,300.00 |
|---|---|
| 52-week range | 94,000.00 – 169,000.00 |
| Return, 1 month / 3 months | −12.8% / +0.6% |
| Return, 1 year / 3 years | +4.7% / +9.0% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 48.6% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 36,271.38M KRW |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Amorepacific Corp. is a South Korean beauty and personal care company based in Seoul. It develops and makes skin care, makeup and fragrance products sold under a range of its own brands, and it also produces personal care items such as hair care and oral care goods. Its customers are everyday consumers, and its products reach them through department stores, retail shops and online channels in Korea and in overseas markets.
On this site Amorepacific Corp. (New) appears as a stock on the Korea Exchange (Korea), code 090430, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Amorepacific Corp. (New) (090430) trades on the Korea Exchange in Korea. It last closed at KRW 124,300.00 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 138 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.7% and over the last three months it rose 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -4.6% | ||
| From 52-week high | -24.7% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.6% | ||
| 6-month return | -17.6% | ||
| 12-month return, skipping the last month | 20.0% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 48.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 36,271.38M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.9% |
|---|---|
| 1 month | −12.8% |
| 3 months | +0.6% |
| 6 months | −17.6% |
| 1 year | +4.7% |
| 3 years | +9.0% |
| 5 years | −29.8% |
Signals
| 50-day / 200-day average | 138,526.00 / 130,253.20 |
|---|---|
| Golden / death cross (60 days) | Golden, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5,552.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 1,240.0000 |
| 27 Mar 2025 | KRW 1,125.0000 |
| 27 Dec 2023 | KRW 910.0000 |
| 28 Dec 2022 | KRW 680.0000 |
| 29 Dec 2021 | KRW 980.0000 |
| 29 Dec 2020 | KRW 800.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.